Extract from the Register of European Patents

EP About this file: EP2080514

EP2080514 - Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.12.2011
Database last updated on 09.04.2026
Most recent event   Tooltip30.12.2011No opposition filed within time limitpublished on 01.02.2012  [2012/05]
Applicant(s)For all designated states
Purdue Pharma LP
One Stamford Forum 201 Tresser Boulevard
Stamford, CT 06901 / US
[2011/08]
Former [2009/30]For all designated states
Purdue Pharma LP
One Stamford Forum 201 Tresser Boulevard
Stamford CT 06901 / US
Inventor(s)01 / McKenna, William Henry
10 Longmeadow Road
Yonkers, NY 10704 / US
02 / Mannion, Richard Owen
3860 Green Ridge Road
Furlong, PA 18925 / US
03 / O'Donnell, Edward Patrick
38 Chestnut Court
Basking Ridge, NJ 07920 / US
04 / Huang, Haiyong Hugh
33 Ketley Place
Princeton, NJ 08540 / US
 [2009/30]
Representative(s)Ehlich, Eva Susanne
Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[N/P]
Former [2009/30]Ehlich, Eva Susanne
Maiwald Patentanwalts GmbH Elisenhof Elisenstraße 3
D-80335 München / DE
Application number, filing date09156838.624.08.2007
[2009/30]
Priority number, dateUS20060840244P25.08.2006         Original published format: US 840244 P
[2009/30]
Previously filed application, dateEP2007011498224.08.2007
[2009/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2080514
Date:22.07.2009
Language:EN
[2009/30]
Type: B1 Patent specification 
No.:EP2080514
Date:23.02.2011
Language:EN
[2011/08]
Search report(s)(Supplementary) European search report - dispatched on:EP15.06.2009
ClassificationIPC:A61K31/485, A61K9/22, A61K9/32
[2009/30]
CPC:
A61K9/1641 (EP,US); A61K9/2086 (KR); A61K9/0002 (CN,KR,US);
A61K31/485 (EP,CN,EA,KR,US); A61K9/28 (KR,US); A61J3/005 (US);
A61J3/06 (US); A61J3/10 (US); A61K45/06 (US);
A61K47/10 (US); A61K47/34 (KR,US); A61K9/0053 (US);
A61K9/16 (KR); A61K9/2013 (EP,US); A61K9/2018 (US);
A61K9/2027 (US); A61K9/2031 (EP,CN,US); A61K9/2054 (EP,US);
A61K9/2077 (US); A61K9/209 (US); A61K9/2095 (EP,US);
A61K9/284 (US); A61K9/2853 (EP,US); A61K9/2866 (EP,CN,US);
A61K9/2893 (US); A61P25/00 (EP); A61P25/04 (EP);
A61P29/00 (EP); A61P29/02 (EP); B29B7/02 (US);
B29B7/88 (US); B29C35/045 (US); B29C35/16 (US);
B29C37/0025 (US); B29C43/003 (US); B29C43/02 (US);
B29C43/52 (US); B29C71/00 (US); B29C71/009 (US);
A61K9/2072 (EP,US); B29C2035/046 (US); B29C2035/1658 (US);
B29K2071/02 (US); B29K2105/0035 (US); B29K2105/251 (US);
B29K2995/0088 (US); B29L2031/753 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/30]
Extension statesAL18.01.2010
BA18.01.2010
HR18.01.2010
MK18.01.2010
RS18.01.2010
TitleGerman:Manipulationssichere orale pharmazeutische Dosierformen enthaltend ein Opiatanalgetikum[2009/30]
English:Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic[2009/30]
French:Formes de dosage pharmaceutiques orales anti-manipulation contenant un analgésique opioide[2009/30]
Examination procedure31.03.2009Examination requested  [2009/30]
14.07.2009Despatch of a communication from the examining division (Time limit: M08)
19.03.2010Reply to a communication from the examining division
17.05.2010Despatch of a communication from the examining division (Time limit: M04)
14.07.2010Reply to a communication from the examining division
10.08.2010Communication of intention to grant the patent
20.12.2010Fee for grant paid
20.12.2010Fee for publishing/printing paid
Parent application(s)   TooltipEP07114982.7  / EP1897545
Opposition(s)24.11.2011No opposition filed within time limit [2012/05]
Fees paidRenewal fee
07.08.2009Renewal fee patent year 03
06.08.2010Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E] EP1859789  (GRUENENTHAL GMBH et al.) [E] 1-43 * example - *
 [X] US2005031546  (BARTHOLOMAUS JOHANNES et al.) [X] 1-43 * example - *
 [X] WO2005016313  (GRUENENTHAL GMBH et al.) [X] 1-43 * example 1 *
 [X] WO2005102286  (GRUENENTHAL GMBH et al.) [X] 1-43 * example - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.